David Toung
Stock Analyst at Argus Research
(4.60)
# 939
Out of 4,690 analysts
343
Total ratings
65.3%
Success rate
9.6%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELV Elevance Health | Maintained: Hold | n/a | $394.43 | - | 6 | Aug 20, 2026 | |
| HCA HCA Healthcare | Rated: Buy | $500 | $417.82 | +19.67% | 5 | Aug 7, 2026 | |
| PFE Pfizer | Maintained: Buy | n/a | $27.96 | - | 13 | Aug 5, 2026 | |
| BSX Boston Scientific | Downgraded: Hold | n/a | $46.84 | - | 11 | Jul 30, 2026 | |
| JNJ Johnson & Johnson | Rated: Buy | $210 → $300 | $268.04 | +11.92% | 14 | Jul 28, 2026 | |
| DGX Quest Diagnostics | Maintained: Buy | $175 → $260 | $242.76 | +7.10% | 3 | Jul 28, 2026 | |
| DHR Danaher | Rated: Buy | $230 | $216.07 | +6.45% | 6 | Jul 23, 2026 | |
| UNH UnitedHealth Group | Maintained: Buy | $400 → $470 | $392.95 | +19.61% | 15 | Jul 17, 2026 | |
| SYK Stryker | Rated: Buy | $450 → $370 | $330.69 | +11.89% | 12 | Jul 9, 2026 | |
| IART Integra LifeSciences Holdings | Upgraded: Buy | $25 | $16.89 | +48.02% | 7 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $310 | $335.11 | -7.49% | 3 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $261.75 | - | 5 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $90.21 | - | 2 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $610 → $560 | $622.18 | -9.99% | 10 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 | $91.23 | +26.06% | 18 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $290 → $180 | $189.52 | -5.02% | 16 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $400 | $322.03 | +24.21% | 19 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $95 | $71.73 | +32.45% | 3 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $91.12 | - | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $385.54 | - | 21 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 → $68 | $72.35 | -6.01% | 10 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $200 | $291.50 | -31.39% | 11 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $570 → $775 | $893.39 | n/a | 15 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 | $112.47 | n/a | 12 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.50 | n/a | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $995.02 | n/a | 1 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $450 → $520 | $372.60 | n/a | 8 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $150 | $100.91 | n/a | 15 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $665 → $770 | $1,174.61 | n/a | 9 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $265 → $300 | $432.42 | n/a | 5 | Nov 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $125 | $148.35 | n/a | 10 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $75 | $145.68 | n/a | 11 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $66.58 | n/a | 6 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $140 | $255.48 | n/a | 14 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $153.81 | n/a | 2 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $234.55 | n/a | 10 | Aug 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $218.50 | n/a | 1 | Feb 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $19 | $4.90 | n/a | 3 | Oct 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $26.13 | n/a | 3 | Aug 15, 2016 |
Elevance Health
Aug 20, 2026
Maintained: Hold
Price Target: n/a
Current: $394.43
Upside: -
HCA Healthcare
Aug 7, 2026
Rated: Buy
Price Target: $500
Current: $417.82
Upside: +19.67%
Pfizer
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $27.96
Upside: -
Boston Scientific
Jul 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $46.84
Upside: -
Johnson & Johnson
Jul 28, 2026
Rated: Buy
Price Target: $210 → $300
Current: $268.04
Upside: +11.92%
Quest Diagnostics
Jul 28, 2026
Maintained: Buy
Price Target: $175 → $260
Current: $242.76
Upside: +7.10%
Danaher
Jul 23, 2026
Rated: Buy
Price Target: $230
Current: $216.07
Upside: +6.45%
UnitedHealth Group
Jul 17, 2026
Maintained: Buy
Price Target: $400 → $470
Current: $392.95
Upside: +19.61%
Stryker
Jul 9, 2026
Rated: Buy
Price Target: $450 → $370
Current: $330.69
Upside: +11.89%
Integra LifeSciences Holdings
Jun 17, 2026
Upgraded: Buy
Price Target: $25
Current: $16.89
Upside: +48.02%
Jun 2, 2026
Maintained: Buy
Price Target: $310
Current: $335.11
Upside: -7.49%
May 29, 2026
Maintained: Buy
Price Target: n/a
Current: $261.75
Upside: -
May 21, 2026
Maintained: Buy
Price Target: n/a
Current: $90.21
Upside: -
Apr 30, 2026
Maintained: Buy
Price Target: $610 → $560
Current: $622.18
Upside: -9.99%
Apr 6, 2026
Maintained: Buy
Price Target: $115
Current: $91.23
Upside: +26.06%
Mar 20, 2026
Rated: Buy
Price Target: $290 → $180
Current: $189.52
Upside: -5.02%
Mar 17, 2026
Reiterated: Buy
Price Target: $280 → $400
Current: $322.03
Upside: +24.21%
Mar 3, 2026
Rated: Buy
Price Target: $110 → $95
Current: $71.73
Upside: +32.45%
Dec 12, 2025
Maintained: Buy
Price Target: n/a
Current: $91.12
Upside: -
Dec 8, 2025
Maintained: Hold
Price Target: n/a
Current: $385.54
Upside: -
Nov 20, 2025
Rated: Buy
Price Target: $65 → $68
Current: $72.35
Upside: -6.01%
Nov 17, 2025
Upgraded: Buy
Price Target: $200
Current: $291.50
Upside: -31.39%
Aug 20, 2025
Rated: Buy
Price Target: $570 → $775
Current: $893.39
Upside: n/a
Apr 21, 2025
Maintained: Buy
Price Target: $150
Current: $112.47
Upside: n/a
Mar 26, 2025
Maintained: Hold
Price Target: n/a
Current: $6.50
Upside: n/a
Aug 15, 2024
Rated: Buy
Price Target: n/a
Current: $995.02
Upside: n/a
Jul 23, 2024
Maintained: Buy
Price Target: $450 → $520
Current: $372.60
Upside: n/a
May 20, 2024
Upgraded: Buy
Price Target: $150
Current: $100.91
Upside: n/a
Feb 7, 2024
Maintained: Buy
Price Target: $665 → $770
Current: $1,174.61
Upside: n/a
Nov 6, 2023
Maintained: Buy
Price Target: $265 → $300
Current: $432.42
Upside: n/a
Jun 6, 2023
Maintained: Buy
Price Target: $115 → $125
Current: $148.35
Upside: n/a
Jan 28, 2022
Upgraded: Buy
Price Target: $75
Current: $145.68
Upside: n/a
Nov 1, 2021
Downgraded: Hold
Price Target: n/a
Current: $66.58
Upside: n/a
Aug 5, 2021
Maintained: Buy
Price Target: $115 → $140
Current: $255.48
Upside: n/a
Mar 10, 2021
Downgraded: Hold
Price Target: n/a
Current: $153.81
Upside: n/a
Aug 27, 2019
Downgraded: Hold
Price Target: n/a
Current: $234.55
Upside: n/a
Feb 16, 2018
Downgraded: Hold
Price Target: n/a
Current: $218.50
Upside: n/a
Oct 21, 2016
Reiterated: Buy
Price Target: $17 → $19
Current: $4.90
Upside: n/a
Aug 15, 2016
Maintained: Hold
Price Target: n/a
Current: $26.13
Upside: n/a